- Open Access
Possible role of glial cells in the onset and progression of Lyme neuroborreliosis
© Ramesh et al; licensee BioMed Central Ltd. 2009
- Received: 24 July 2009
- Accepted: 25 August 2009
- Published: 25 August 2009
Lyme neuroborreliosis (LNB) may present as meningitis, cranial neuropathy, acute radiculoneuropathy or, rarely, as encephalomyelitis. We hypothesized that glia, upon exposure to Borrelia burgdorferi, the Lyme disease agent, produce inflammatory mediators that promote the acute cellular infiltration of early LNB. This inflammatory context could potentiate glial and neuronal apoptosis.
We inoculated live B. burgdorferi into the cisterna magna of rhesus macaques and examined the inflammatory changes induced in the central nervous system (CNS), and dorsal root nerves and ganglia (DRG).
ELISA of the cerebrospinal fluid (CSF) showed elevated IL-6, IL-8, CCL2, and CXCL13 as early as one week post-inoculation, accompanied by primarily lymphocytic and monocytic pleocytosis. In contrast, onset of the acquired immune response, evidenced by anti-B. burgdorferi C6 serum antibodies, was first detectable after 3 weeks post-inoculation. CSF cell pellets and CNS tissues were culture-positive for B. burgdorferi. Histopathology revealed signs of acute LNB: severe multifocal leptomeningitis, radiculitis, and DRG inflammatory lesions. Immunofluorescence staining and confocal microscopy detected B. burgdorferi antigen in the CNS and DRG. IL-6 was observed in astrocytes and neurons in the spinal cord, and in neurons in the DRG of infected animals. CCL2 and CXCL13 were found in microglia as well as in endothelial cells, macrophages and T cells. Importantly, the DRG of infected animals showed significant satellite cell and neuronal apoptosis.
Our results support the notion that innate responses of glia to B. burgdorferi initiate/mediate the inflammation seen in acute LNB, and show that neuronal apoptosis occurs in this context.
- Satellite Cell
- Neuronal Apoptosis
- Lyme Disease
- Immune Mediator
- Central Nervous System Tissue
Lyme neuroborreliosis (LNB) is caused by the spirochete Borrelia burgdorferi. It manifests in 10–15% of untreated Lyme disease patients . LNB affects both the peripheral and the central nervous systems (CNS), resulting in acute and chronic inflammation accompanied with neurological deficits that may persist for the lifetime of a patient . Neuroborreliosis may present as meningitis, cranial neuropathy, transverse myelitis, acute radiculoneuropathy or, rarely, as encephalomyelitis . Early symptoms after an acute attack of LNB may include severe headaches, chronic fatigue and flu-like symptoms, facial-nerve paralysis, and motor dysfunction presenting as acute ataxia with pain in the back and extremities of limbs, accompanied by cognitive disorders and depression .
A sign of acute meningitis of both bacterial and viral origin is migration of large numbers of leukocytes into the subarachnoid space, with such pleocytosis reaching values of 100 to 1000 cells per μL . Under normal conditions, cerebrospinal fluid (CSF) contains 1–5 leukocytes per μL . In meningitis caused by bacteria such as Neisseria meningitidis, Haemophilus influenza, or Streptococcus pneumoniae the local production of cytokines and chemokines by glial and endothelial cells upon contact with pathogens is currently regarded as the initial step in regulating the directed migration of distinct leukocyte populations to an inflammatory site within the CNS [7–10]. In Lyme meningitis the cellular sources of these mediators are unknown.
The CSF of LNB patients shows abnormalities within 3 to 6 weeks after infection, manifested as mononuclear pleocytosis, persistent plasma cells, intrathecal synthesis of B. burgdorferi-specific immunoglobulins and presence of B. burgdorferi DNA . Immune mediators such as cytokines and chemokines implicated in playing a role in the pathogenesis of various inflammatory diseases of the nervous system have also been found in the CSF of LNB patients [12–19]. Further, microscopic evaluation of lesions from patients with LNB shows perivascular monocytic and lymphocytic cell infiltration concomitant with the presence of B. burgdorferi DNA [20, 21].
Recently, we reported that the interaction of B. burgdorferi with rhesus monkey brain parenchyma elicits the inflammatory mediators IL-6, IL-8, IL-1beta and CXCL13 from glial cells, with concomitant oligodendrocyte and neuronal apoptosis . In addition, primary cultures of microglia or astrocytes produced IL-6, TNF-alpha, IL-8, and the macrophage inflammatory proteins CCL3 and CCL4 in the presence of live B. burgdorferi . Several of these mediators are associated with LNB [24, 25], play a major role in the recruitment of leukocytes into the subarachnoid space in various types of infectious meningitis , and in the inflammatory response mounted by the CNS in other neurodegenerative diseases such as multiple sclerosis and experimental autoimmune encephalomyelitis [27, 28]. We therefore reasoned that glial cells could be an early source of the cytokines and chemokines detected in the CSF during LNB. We further anticipated that this inflammatory context could potentiate glial and neuronal apoptosis, based on our earlier observations that documented that live B. burgdorferi induced inflammation and oligodendrocyte and neuronal apoptosis in brain explants ex vivo, and following intracerebral inoculation in vivo .
To address our hypotheses we devised an in vivo model of acute LNB in the rhesus monkey. Five rhesus macaques were given intrathecal inoculations with live B. burgdorferi, and 2 additional animals were given sham inoculations and served as controls. CSF and serum samples were serially collected over a 6-week period from 2 of the infected animals and one control, and over a 12-week period from the other 3 animals and the other control. Relative concentrations of cytokines and chemokines were determined in CSF and serum by multiplex and sandwich ELISA assays, to determine the immune mediators that were specifically associated with the initiation of Lyme meningitis along with the appearance of pleocytosis. CSF cell pellets, and tissues from various regions of the brain and spinal cord were cultured for spirochetes to evaluate the presence of active infection. Levels of anti-C6 antibodies  were determined in serial serum samples to monitor the appearance of the acquired immune response against B. burgdorferi. Histopathological evaluation, immunohistochemistry, immunofluorescence staining and confocal microscopy of sections from the brain, spinal cord, dorsal root ganglia (DRG) and heart tissues were performed post-necropsy to detect the presence of inflammatory lesions, B. burgdorferi antigen, and to identify the cells that produced immune mediators. We also looked for glial and neuronal apoptosis in the parenchyma of the brain and spinal cord, and in DRG by the in situ TUNEL assay. The results of these evaluations are described herein.
B. burgdorferi strain B31 clone 5A19 spirochetes, passage one, isolated from an ear biopsy of a previously infected mouse, were grown in Barbour-Stoenner-Kelly (BSK)-H medium supplemented with 6% rabbit serum and antibiotics (Rifampicin at 45.4 mg/ml, Phosphomycin at 193 mg/ml and Amphotericin at 0.25 mg/ml) (Sigma, St. Louis, MO) to late logarithmic phase under microaerophilic conditions. Spirochetes were pelleted at 2000 × g for 30 min at RT. At the end of the run the rotor was left to coast without breaking so as to minimize damage to the live spirochetes. The culture was washed twice using phosphate buffered saline (PBS) pH 7.2 (Invitrogen, Grand Island, NY) and resuspended in RPMI 1640 medium (Biowhittaker, Walkersville, MD) to contain a suspension of 1 × 108 spirochetes/ml.
Animals and intrathecal inoculation
Seven 3–7-year old male rhesus macaques (Macaca mulatta) of Chinese origin were used in this study. The inoculation protocol was approved by the Institutional Animal Care and Use Committee of the Tulane National Primate Research Center. Anesthetized animals received up to 1 ml of RPMI 1640 medium with 1 × 108 spirochetes (n = 5), or no spirochetes (n = 2) into the cisterna magna, after removal of an equivalent volume of CSF. This dose was found to be safe in studies involving intrathecal inoculation of Treponema pallidum, another spirochete, in rhesus macaques . Similar inoculum doses were used previously in the rhesus monkey [31–34]. To monitor CNS inflammation following inoculation, CSF (0.5–1.0 ml) and serum (5 ml of blood) were collected on a weekly basis for 4 weeks, and then once every two weeks until the end of the study for each animal. Two inoculated animals (DR50, EL81) and one control (EL66) were necropsied at six weeks post-inoculation (PI) and three inoculated animals (DH50, EP51, CH82) and one control (EJ86) at 12 weeks PI. The procedure used for euthanasia was consistent with the recommendations of the American Veterinary Medical Association's Panel on Euthanasia.
CSF cell enumeration, and B. burgdorfericulture
CSF samples were maintained on ice after collection until processed. Total cell numbers were determined using a Reichert Bright-Line metalized hemocytometer (Thermo Fisher Scientific, Waltham, MA) within 30 min of collection. For cytospin, preparations were made by centrifuging the CSF at 300 × g at 4°C for 10 min. The cell pellet was resuspended in 100 ml of fetal bovine serum, loaded in a Shandon EZ cytofunnel set up on positively charged slides, and spun at 700 rpm for 7 min with minimum acceleration on a Shandon Cytospin centrifuge (Thermo Fisher Scientific). Slides were air-dried and stained with Wright stain (Fisher Scientific, Pittsburg, PA), mounted, and stored at RT until evaluation. Slides were examined for cellular composition and cell morphology. A 100–200 nucleated-cell differential count was performed from multiple random areas of each slide under a 40 × objective. The CSF supernatant after removal of cells was collected and spun down at 8000 × g at 4°C for 20 min. The supernatant was aliquoted and frozen at -70°C for evaluation of immune mediators. The pellet was resuspended in 10 ml BSK-H medium, supplemented with 6% rabbit serum and antibiotics as described above (Sigma) for culture of B. burgdorferi.
Detection of anti-VlsE (C6) antibodies in serum
Serum antibody levels to the VlsE C6 peptide (B. burgdorferi B31) were quantified by ELISA using a procedure described previously . As is customary, the cut-off line for positive ELISA values was set at the mean value of all of the pre-immune serum specimens plus three times the standard deviation of that mean. The probability that an ELISA value above this cut-off line is negative is p = 0.003.
Quantification of immune mediators in CSF and serum
CSF and serum cytokines and chemokines were quantified with the Bio-Plex Human Cytokine 17-Plex Panel following the manufacturer's instructions (Bio-Rad, Hercules, CA). The analytes detected by this panel are: Hu IL-1beta, Hu IL-2, Hu IL-4, Hu IL-5, Hu IL-6, Hu IL-7, Hu IL-8, Hu IL-10, Hu IL-12, Hu IL-13, Hu IL-17, Hu G-CSF, Hu GMCSF, Hu IFN-gamma, Hu MCP-1/CCL2, Hu MIP-1beta/CCL4, Hu TNF-alpha. The multiplex plate was read using a Bio-Plex 200 Suspension Array Luminex System (Bio-Rad). CXCL13 concentration was measured with a sandwich ELISA (R&D, Minneapolis, MN). As with the serology ELISA, the cut-off line for positive Bio-Plex and sandwich ELISA values was set at the mean value for each mediator of all of the pre-infection and control CSF specimens plus three times the standard deviation of that mean.
Collection of tissues for histopathological evaluation, detection of intracytoplasmic localization of immune mediators, and detection of B. burgdorferiby culture
Tissues were collected from various regions of the brain and spinal cord and DRG, and fixed in formalin or Z-fixative (Anatech, Battle Creek, MI) for routine histopathological evaluation. For the purpose of detecting intracytoplasmic localization of cytokines, fresh unfixed tissues were collected from various regions of the brain and spinal cord, as well as DRG at necropsy, and immediately processed for blocking of intracytoplasmic cytokines (modification of the method previously described , by incubation of tissue slices for four hours in RPMI medium (Invitrogen) containing 10% fetal bovine serum (Invitrogen) and the fungal metabolite brefeldin A (Invitrogen), which blocks export of intracellular proteins via the endoplasmic reticulum. Tissues were then fixed in 2% paraformaldehyde in PBS pH 7.0 (USB, Cleveland OH), and cryopreserved as described previously . Tissue samples from various regions of the brain and spinal cord were also collected at necropsy in BSK-H medium, supplemented with 6% rabbit serum and antibiotics (Sigma) for detection of B. burgdorferi by culture.
Immunofluorescence staining of intracytoplasmic immune mediators, phenotypic markers of producer cells and of cells in inflammatory lesions
For in situ analysis, the cryopreserved tissues were cryosectioned into 16-μm sections as previously described . Tissues collected in formalin or fixed with Z-fixative were also sectioned into 10–15 μm sections, depending on the availability of tissue. Presence of inflammatory lesions was determined by routine histopathological evaluation of tissues sectioned at 5 μm and stained with hematoxylin and eosin (H&E). Immunohistochemical staining was done using several monoclonal and polyclonal antibodies (anti-CD3, CD20, and CD68, Table 1). All histological sections were incubated with the primary antibody for 1 hour at room temperature, followed by biotinylated anti-rabbit or anti-mouse secondary antibodies (Dako) as appropriate for 30 minutes. Finally, sections were incubated with avidin-biotin complex (ABC) (Vector labs, Burlingame, CA) for 30 minutes, and the reaction was visualized with 3,3'-diaminobenzidine (Dako) as the chromogen. Sections were subjected to immunofluorescence staining as previously described . The primary antibodies against various immune mediators, cell phenotypic markers and B. burgdorferi are listed in Table 1. Relevant isotype controls (Sigma) at the concentration of the corresponding primary antibodies were also included.
Qualitative and quantitative assessment of glial and neuronal apoptosis
Primary antibody and antibody/fluorochrome-conjugates against various immune mediators, B. burgdorferi, and cell phenotypes
(Abcam Inc. Cambridge, MA)
RDI Flanders, NJ
anti-whole cell preparation
(Accurate Chemicals, Westbury, NY)
anti- B. burgdorferi-FITC
(Kirkegaard and Perry, Gaithersburg, MD)
(Sigma St Louis, MO)
Astrocyte, Oligodendrocyte, Schwann cell, satellite cell
anti-Iba1 synthetic peptide
(Wako Pure Chemicals, Richmond, VA)
(Dako, Carpinteria, CA)
Confocal microscopy was performed using a Leica TCS SP2 confocal microscope (Leica Microsystems, Exton, PA) as previously described . Photoshop CS3 (Adobe systems Inc., San Jose, CA) was used for image processing.
The statistical significance of the apoptosis data was evaluated using the one-way ANOVA non-parametric analysis, followed by the Tukey's stringency test using PRISM software (IBM).
Intrathecal inoculation with B. burgdorferiresults in active, persistent CNS infection
Live B. burgdorferi spirochetes were recovered from the CSF cell pellets of all but one of the inoculated animals at various time points PI, as follows: animals DR50 and EL81 at week 6, DH50 at week 2 and EP51 at week 10, except for animal CH82, whose CSF cell-pellet cultures yielded no spirochetes. Tissues harvested at necropsy from the dura mater and the cervical spinal cord of one of the two animals (EL81) that were inoculated with B. burgdorferi and euthanized 6 weeks PI were also culture positive for B. burgdorferi. CSF cell-pellet or tissue cultures of the control animals were negative throughout.
Early appearance of pleocytosis and inflammatory mediators in CSF
Cerebrospinal fluid pleocytosis
CEREBROSPINAL FLUID NUCLEATED CELL COUNT/μl
Peak CSF and corresponding serum values (pg/ml) of immune mediators in animals that were inoculated with B. burgdorferi.
17.8 ± 0.4
10 ± 0.9
3.7 ± 0.5
46.9 ± 0.2
2.9 ± 0.7
0.7 ± 0.2
0.3 ± 0.05
1 ± 0.2
3.9 ± 0.5
33.4 ± 4.2
15.7 ± 0.1
21.9 ± 1.0
34.5 ± 0.9
10.9 ± 2.0
832.8 ± 75
697.6 ± 86.2
625.6 ± 3.7
3442 ± 149.2
422.4 ± 25
475.9 ± 25.2
345.6 ± 62.3
404.5 ± 6.8
442.3 ± 6.8
114.1 ± 6.5
71.8 ± 0.4
106.2 ± 2.8
39 ± 11.2
5317.8 ± 70.5
Evaluation of the time of onset of the acquired immune response
Histopathological evidence of Lyme meningitis, radiculitis, and inflammation in the DRG, along with evidence of B. burgdorferiantigen in both the CNS and peripheral nervous system (PNS) of infected animals
Glial cells and neurons are among the producers of inflammatory mediators
IL-6, CCL2 and CXCL13 were undetectable in comparable tissues from control animals (Fig. 5E, F, and 5G). No IL-6 was detected in astrocytes from the spinal cord or in neurons from the DRG of a control animal (Fig 5E and 5F, respectively). Similarly, microglia from the spinal cord of control animals were devoid of mediators (IL-6, IL-8, CCL2 or CXCL13). A representative image of microglia lacking CCL2 is shown in Fig 5G. Non-specific signals were absent in contiguous sections that were stained with immunoglobulin isotype controls at the concentrations of the respective primary antibodies, followed by the corresponding secondary antibodies.
Glial and neuronal apoptosis
This study depicts an in vivo model of acute LNB in the rhesus monkey. The model evidences the key features of CSF pleocytosis, as well as the classical lesions of leptomeningitis of brain and spinal cord and radiculitis that have been reported in patients with early LNB [2, 4, 11–15]. Importantly, live spirochetes were detected by culture of CSF cell pellets and CNS tissues collected post-mortem. This finding provides evidence of active CNS infection in this model.
Elevated CSF levels of both cytokines and chemokines have been reported in Lyme meningitis patients. The model not only reproduced these features but also provided, in addition, an insight into whether key inflammatory mediators did originate within the CNS or in the periphery, and an indication of the cellular sources of these mediators. That glia, and thus innate immune processes, are at least in part the source of relevant cytokines and chemokines was further suggested by the very early appearance of pleocytosis, likely caused by the enhanced concentration of these mediators in CSF within the first week PI. Acquired immunity, measured as serum antibody to VlsE, was only evident by week 3 PI, and later than week 3 in most animals. Perhaps the most significant finding was that of neuronal and Schwann/satellite cell apoptosis in DRG. As we discuss below, this phenomenon provides a probable etiology for Lyme neuroborreliosis of the PNS.
The evidence of pleocytosis by weeks 1–2 PI in all of the inoculated animals coincided with elevated levels of immune mediators (Table 1, Fig 2). This correlation indicates, but does not prove, that these immune mediators had a role in mobilizing the immune cells from the periphery into the CNS. The low levels of pleocytosis and immune mediators in animal CH82, as well as the lack of anti-C6 antibody response, could be due to an early clearance of active infection in this animal.
The ability to culture spirochetes from CSF cell pellets and CNS tissue and the occurrence of pleocytosis concomitant with an increase of immune mediators in the CSF implies that these phenomena occurred as a response to the presence of live spirochetes and spirochetal antigens in the CNS. The influx of immune cells from the periphery into the CNS is reflected in the cellular composition of the inflammatory lesions that were identified in the brain, spinal cord, dorsal root nerves and DRG of infected animals. The presence of B. burgdorferi antigen in CNS tissues and DRG located in the vicinity of inflammatory lesions indicates that the Lyme spirochete could have contributed to the induction of the acute inflammatory response both in the CNS as well as the PNS (DRG).
As chemokines are known to regulate inflammatory processes in the CNS in various bacterial and viral meningitides , acute Lyme meningitis could also be initiated via signaling mechanisms mediated by cytokines and chemokines, produced by glial cells in response to the Lyme spirochete. The presence of T cells and monocytes in lesions and in the CSF of spirochete-inoculated animals in this study, as well as those observed in the CSF of human patients with LNB, could be a consequence of the chemotactic action of the chemokine CCL2/MCP-1 [13, 37, 38]; this chemokine is also involved in enhancing production of inflammatory/immune cells from the bone marrow, an important feature that can assist in recruitment of these cells to the CNS. CCL2 was evident in the CNS as early as week 2 PI, and was shown to be produced by microglia. Moreover, its concentration in the CSF was up to 11 times higher than it was in the serum, in paired specimens of both fluids (Table 3); this is evidence to suggest that CCL2 was initially produced in the CSF. Considering that this chemokine has other important functions in the CNS, such as altering blood-brain barrier permeability , and affecting the survival of neuronal cells in other inflammatory neurodegenerative diseases such as multiple sclerosis and Alzheimer's disease [21, 23, 28, 40–44], CCL2 could possibly be a contributor to the neurodegeneration [21, 44] and vasculitis [3, 44] observed in LNB.
The abundance of B cells in the lesions of spirochete-inoculated animals could be a consequence of the chemotactic activity of the B lymphocyte chemoattractant CXCL13. This chemokine was elevated in CSF by week 2 PI, and the fact that its concentration in CSF was in most cases higher than in paired serum specimens indicates, as with CCL2, that CXCL13 was primarily produced in the CNS. Our finding that microglia are among the cells that serve as a source of CXCL13 in the CNS corroborates our previous results that document the production of this chemokine by microglia in rhesus monkey brain explants that were exposed to B. burgdorferi . It also echoes the observations of others who suggested a role for CXCL13 in LNB [24, 25], and entails a possible driving force for the intrathecal B-cell infiltration and antibody production commonly observed in patients with spirochetal diseases.
The neutrophil attractant IL-8, which was detected in the CSF as early as week one PI, is likely a cause of the early accumulation of neutrophils in the CSF. Interestingly, even at this early time point, the concentration of IL-8 in serum was up to 100 times higher than that in the CSF (Table 3). No IL-8 was found in glial cells, in tissues collected at necropsy, even though this cytokine is produced in vitro both by astrocytes and microglia co-cultured with B. burgdorferi .
IL-6, which was already elevated in CSF by week one PI, could be contributed by glial cells, based on our observation of the localization of IL-6 to astrocytes, as well as to neurons. IL-6 has been documented to play a role in mediating inflammation in various inflammatory diseases of the nervous system [45–48] and in the pathogenesis of LNB [49, 50]. Our observations affirm our previous report documenting astrocyte-derived IL-6 in response to live B. burgdorferi . We have also previously shown that live B. burgdorferi as well as purified lipoproteins from this spirochete are able to induce the production of IL-6 in primary cultures of rhesus glial cells [23, 51].
The role of microglia in initiating or promoting inflammatory processes in the CNS by facilitating the recruitment of peripheral immune cells has been well documented [52–54]. Here, we show that microglia can contribute the chemokines CCL2 and CXCL13 in the CNS and that the innate immune response mounted against the Lyme spirochete in the CNS, as evidenced by the appearance of immune mediators in the CSF, occurs before the onset of the acquired immune response. The latter was measured by the appearance of anti-C6 (VlsE) serum antibody. The induction of a syndrome indistinguishable from acute LNB prior to the onset of specific acquired immunity indicates that this syndrome can be induced by innate immune mechanisms, thus providing an insight into the pathogenesis of the acute form of the disease.
An important finding of this study is the significant Schwann/satellite cell and neuronal apoptosis in the DRG of B. burgdorferi-infected animals. This finding corroborates previous observations made in an ex vivo model of the interaction of live B. burgdorferi with brain explants from the frontal cortex of rhesus brain . Our failure to find significant apoptosis in the brain and spinal cord in the in vivo model may be due to limited interaction of B. burgdorferi with parenchymal tissue, compounded with clearance of apoptotic cells by phagocytes such as macrophages and microglia . In contrast, the detection of apoptotic cells in the DRG could be brought about by a delay in the recruitment of phagocytic cells to this area or by the presence of a larger concentration of neurons and Schwann/satellite cells per unit volume in the DRG as compared to neurons and oligodendrocytes in the parenchyma.
Mechanisms of neuronal damage as a consequence of bacterial meningitis have been studied extensively [56, 57]. Neural injury has been documented in experimental neonatal meningitis due to group B streptococci . The neurological sequelae of meningitis caused by Streptococcus pneumoniae also include neuronal dysfunction due to neuronal apoptosis . Similar mechanisms of neuronal damage and neuronal dysfunction could be contributing to the cognitive and memory impairment seen in patients with LNB.
Neuroinflammation during bacterial meningitis is known to affect both neuronal synaptic plasticity as well as neuronal survival. Death of Schwann/satellite cells could also result in impaired neuronal function [60, 61]. As we have shown that Lyme meningitis sets the stage for neuroinflammation and Schwann/satellite cell and neuronal damage, immune-mediated glial and neuronal damage could be among the underlying mechanisms of the cognitive and memory loss seen in LNB patients. The axonal damage observed in the PNS in LNB patients as well as in the rhesus monkey model of Lyme disease [62, 63] could be a result of immune mediated death of DRG neurons, resulting in impaired nerve function.
Another potentially relevant finding of this study is the presence of IL-6 in neurons of DRG in infected animals. The induction of IL-6 in neurons of adult rat DRG that are adjacent to injured peripheral nerves has been shown to be a specific response to nerve injury [64, 65]. IL-6 is suggested to play a critical role in affecting the activity of neurons in the DRG, increasing the receptiveness of neurons at nerve endings, axons as well as nerve cell bodies, resulting in lower back pain and sciatica . IL-6-mediated signaling in glial cells in the spinal cord after spinal nerve injury is also known to play a role in the transduction of pain . Thus the cytokine IL-6 produced in neuronal cells in the DRG as well as in glial and neuronal cells in the spinal cord that we observed in this model could be a possible factor contributing to the transduction of the lumbar pain that is often observed in patients with LNB.
In conclusion, the findings of this study emphasize that glial cells are among the sources of a distinct set of immune mediators particularly the cytokines IL-6, and the chemokines CCL2 and CXCL13, in response to the Lyme spirochete in the CNS. Importantly, the observation of Schwann cell and/or satellite cell and neuronal apoptosis in the DRG as well as the inflammatory cytokine IL-6 in neurons in this region lend support to our hypothesis that the direct interaction of the spirochete with neural cells, a phenomenon that had long been predicted by experiments performed in vitro [68, 69], and the ensuing immune response, may result in neurological damage. Our results are consistent with the notion that innate immune responses of glial cells to the Lyme disease spirochete initiate and/or mediate the inflammation that characterizes acute Lyme meningitis, and provide evidence of concomitant apoptotic cell death in the DRG. The latter could be the early event that leads to peripheral neuropathy in LNB.
We thank Robin Rodriguez for help with the confocal microscope images. This work was supported by the National Institutes of Health grants [NS048952, RR00164, to MTP].
- Halperin JJ: Nervous system Lyme disease. Infect Dis Clin North Am. 2008, 22: 261-274. 10.1016/j.idc.2007.12.009. vi.View ArticlePubMedGoogle Scholar
- Halperin JJ: Neuroborreliosis. Am J Med. 1995, 98: 56S-59S. 10.1016/S0002-9343(99)80044-8. discussion 56S-59SView ArticleGoogle Scholar
- Rupprecht TA, Koedel U, Fingerie V, Pfister HW: The pathogenesis of Lyme neuroborreliosis: from infection to inflammation. Mol Med. 2008, 14: 205-212.PubMed CentralPubMedGoogle Scholar
- Gustaw K, Beltowska K, Studzinska MM: Neurological and psychological symptoms after severe acute neuroborreliosis. Ann Agric Environ Med. 2001, 8: 91-94.PubMedGoogle Scholar
- Fishman RA: Cerebrospinal Fluid in Diseases of the Nervous System. 1992, Philadelphia, USA: W. B. Saunders Company, 253-343.Google Scholar
- Leist TP, Frei K, Kam-Hansen S, Zinkernagel RM, Fontana A: Tumor necrosis factor α in cerebral fluid during bacterial, but not viral meningitis. Evaluation in murine model infections and patients. J Exp Med. 1988, 167: 1743-1748. 10.1084/jem.167.5.1743.View ArticlePubMedGoogle Scholar
- Täuber MG, Moser B: Cytokines and chemokines in meningeal inflammation: biology and clinical implications. Clin Infect Dis. 1999, 28: 1-11. 10.1086/515079.View ArticlePubMedGoogle Scholar
- Ramilo O, Sáez-Llorens X, Mertsola J, Jafari H, Olsen KD, Hansen EJ, Yoshinaga M, Ohkawara S, Nariuchi H, McCracken GH: Tumor necrosis factor alpha/cachectin and interleukin 1beta initiate meningeal inflammation. J Exp Med. 1990, 172: 497-507. 10.1084/jem.172.2.497.View ArticlePubMedGoogle Scholar
- Huber AR, Kunkel SL, Todd RF, Weiss ST: Regulation of transendothelial neutrophil migration by endogenous interleukin 8. Science. 1991, 254: 99-102. 10.1126/science.1718038.View ArticlePubMedGoogle Scholar
- Jiang Y, Beller DI, Frendl G, Graves DT: Monocyte chemoattractant protein-1 regulates adhesion molecule expression and cytokine production in human monocytes. J Immunol. 1992, 148: 2423-2428.PubMedGoogle Scholar
- Holub M, Kluckova Z, Beran O, Aster V, Lobovska A: Lymphocyte subset numbers in cerebrospinal fluid: comparison of tick-borne encephalitis and neuroborreliosis. Acta Neurol Scand. 2002, 106: 302-308. 10.1034/j.1600-0404.2002.01314.x.View ArticlePubMedGoogle Scholar
- Pietruczuk A, Swierzbinska R, Pietruczuk M, Hermanowska-Szpakowicz T: Role of interleukin-18, interleukin-1beta and its soluble receptor (sIL-IRII) in early and late Lyme borreliosis. Pol Merkuriusz Lek. 2004, 17: 446-450.Google Scholar
- Grygorczuk S, Zajkowska J, Swierzbinska R, Pancewicz S, Kondrusik M, Hermanowska-Szpakowicz T: Concentration of interferon-inducible T cell chemoattractant and monocyte chemotactic protein-1 with Lyme borreliosis. Annal Acade Medic Bial. 2005, 50: 173-178.Google Scholar
- Cepok S, Zhou D, Vogel F, Rosche B, Grummel V, Sommer N, Hemmer B: The immune response at onset and during recovery from Borrelia burgdorferi meningoradiculitis. Arch Neurolog. 2003, 60: 849-855. 10.1001/archneur.60.6.849.View ArticleGoogle Scholar
- Weller M, Stevens A, Sommer N, Wietholter H, Dichgans J: Cerebrospinal fluid interleukins, immunoglobulins, and fibronectin in neuroborreliosis. Arch Neurol. 1991, 48: 837-841.View ArticlePubMedGoogle Scholar
- Wang WZ, Fredrikson S, Sun JB, Link H: Lyme neuroborreliosis: evidence for persistent up-regulation of Borrelia burgdorferi – reactive cells secreting interferon-gamma. Scand J Immunol. 1995, 42: 694-700. 10.1111/j.1365-3083.1995.tb03713.x.View ArticlePubMedGoogle Scholar
- Ekerfelt C, Jarefors S, Tynngård N, Hedlund M, Sander B, Bergström S, Forsberg P, Ernerudh J: Phenotypes indicating cytolytic properties of Borrelia -specific interferon-gamma secreting cells on chronic Lyme neuroborreliosis. J Neuroimmunol. 2003, 145: 115-126. 10.1016/j.jneuroim.2003.08.037.View ArticlePubMedGoogle Scholar
- Kondrusik M, Sweirzbinska R, Pancewicz S, Zajkowska J, Grygorczuk S, Hermanowska-Szpakowicz T: Evaluation of proinflammatory cytokine (TNF-alpha, IL-1beta, IL-6, IFN-gamma) concentrations in serum and cerebrospinal fluid of patients with neuroborreliosis. Neurol Neurochir Pol. 2004, 38: 265-70.PubMedGoogle Scholar
- Widhe M, Grusell M, Ekerfelt C, Vrethem M, Forsberg P, Emerudh J: Cytokines in Lyme borreliosis: lack of early tumour necrosis factor-alpha and transforming growth factor-beta1 responses are associated with chronic neuroborreliosis. Immunology. 2002, 107: 46-55. 10.1046/j.1365-2567.2002.01500.x.PubMed CentralView ArticlePubMedGoogle Scholar
- Oksi J, Kalimo H, Marttila RJ, Marjamäki M, Sonninen P, Nikoskelainen J, Viljanen MK: Inflammatory brain changes in Lyme borreliosis. A report on three patients and review of literature. Brain. 1996, 119: 2143-2154. 10.1093/brain/119.6.2143.View ArticlePubMedGoogle Scholar
- Benach JL, Garcia-Monco JC: Aspects of the pathogenesis of neuroborreliosis. Lyme disease; Molecular and immunological approaches. Edited by: Schutzer S. 1992, New York: Cold Spring Harbor PressGoogle Scholar
- Ramesh G, Borda JT, Kaushal D, Ramamoorthy R, Lackner AA, Philipp MT: Interaction of the Lyme disease spirochete Borrelia burgdorferi with brain parenchyma elicits inflammatory mediators from glial cells as well as glial and neuronal apoptosis. Am J Pathol. 2008, 173: 1415-1427. 10.2353/ajpath.2008.080483.PubMed CentralView ArticlePubMedGoogle Scholar
- Bernardino ALF, Myers TA, Alvarez X, Hasegawa A, Philipp MT: Toll-like receptors: Insights into their possible role in the pathogenesis of Lyme neuroborreliosis. Infect Immun. 2008, 76: 4385-4395. 10.1128/IAI.00394-08.PubMed CentralView ArticlePubMedGoogle Scholar
- Narayan K, Dail D, Li L, Cadavid D, Amrute S, Fitzgerald-Bocarsly P, Pachner AR: The nervous system as ectopic germinal center: CXCL13 and IgG in Lyme neuroborreliosis. Ann Neurol. 2005, 57: 813-823. 10.1002/ana.20486.View ArticlePubMedGoogle Scholar
- Rupprecht TA, Pfister HW, Angel B, Kastenbauer S, Wilske B, Koedel U: The chemokine CXCL13 (BLC): a putative diagnostic marker for neuroborreliosis. Neurology. 2005, 65: 448-450. 10.1212/01.wnl.0000171349.06645.79.View ArticlePubMedGoogle Scholar
- Lahrtz F, Piali L, Spanausk S, Seebach J, Fontana A: Chemokines and chemotaxis of leukocytes in infectious meningitis. J Neuroimmunol. 1998, 85: 33-43. 10.1016/S0165-5728(97)00267-1.View ArticlePubMedGoogle Scholar
- Mahad DJ, Ransohoff RM: The role of MCP-1/CCL2 and CCR2 in multiple sclerosis and experimental autoimmune encephalitis (EAE). Semin Immunol. 2003, 15: 23-32. 10.1016/S1044-5323(02)00125-2.View ArticlePubMedGoogle Scholar
- Huang D, Han Y, Rani MR, Glabinski A, Trebst C, Sørensen T, Tani M, Wang J, Chien P, O'Bryan S, Bielecki B, Zhou ZL, Majumder S, Ransohoff RM: Chemokines and chemokine receptors in inflammation of the nervous system: manifold roles and exquisite regulation. Immunol Rev. 2000, 177: 52-67. 10.1034/j.1600-065X.2000.17709.x.View ArticlePubMedGoogle Scholar
- Liang FT, Philipp MT: Analysis of antibody response to invariable regions of VlsE the variable surface antigen of Borrelia burgdorferi. Infect Immun. 1999, 67: 6702-6706.PubMed CentralPubMedGoogle Scholar
- Marra CM, Castro CD, Kuller L, Dukes AC, Centurion-Lara A, Morton WR, Lukehart SA: Mechanisms of clearance of Treponema pallidum from the CSF in a nonhuman primate model. Neurology. 1998, 51: 957-961.View ArticlePubMedGoogle Scholar
- Philipp MT, Aydintug MK, Bohm RP, Cogswell FB, Dennis VA, Lanners HN, Lowrie RC, Roberts ED, Conway MD, Karaçorlu M, Peyman GA, Gubler DJ, Johnson BJ, Piesman J, Gu Y: Early and early-disseminated phases of Lyme disease in the rhesus monkey: A model of infection in humans. Infect Immun. 1993, 61: 3047-3059.PubMed CentralPubMedGoogle Scholar
- Pachner AR, Delaney E, O'Neil T, Major E: Inoculation of nonhuman primates with the N40 strain of Borrelia burgdorferi leads to a model of Lyme neuroborreliosis faithful to the human disease. Neurology. 1995, 45: 165-72.View ArticlePubMedGoogle Scholar
- Cadavid D, O'Neil T, Schaefer H, Pachner AR: Localization of Borrelia burgdorferi in the nervous system and other organs in a nonhuman Primate model of Lyme disease. Lab Invest. 2000, 80: 1043-1054.View ArticlePubMedGoogle Scholar
- Bai Y, Narayan K, Dail D, Sondey M, Hodzic E, Barthold SW, Pachner AR, Cadavid D: Spinal cord involvement in the nonhuman primate model of Lyme disease. Lab Invest. 2004, 84: 160-172. 10.1038/labinvest.3700024.View ArticlePubMedGoogle Scholar
- Ramesh G, Alvarez X, Borda JT, Aye PP, Lackner AA, Sestak K: Visualizing cytokine-secreting cells in situ in the rhesus macaque model of chronic gut inflammation. Clin Diagn Lab Immunol. 2005, 12 (1): 192-197.PubMed CentralPubMedGoogle Scholar
- Albuerne M, Mammola CL, Naves FJ, Levanti B, Germanà G, Vega JA: Immunohistochemical localization of S100 proteins in dorsal root, sympathetic and enteric ganglia of several mammalian species, including man. J Peripher Nerv Syst. 1998, 3: 243-253.PubMedGoogle Scholar
- Randolf GJ, Furie MB: A soluble gradient of endogenous monocyte chemoattractant protein-1 promotes the transendothelial migration of monocytes in vitro. J Immunol. 1995, 155: 3610-18.Google Scholar
- Carr MW, Roth SJ, Luther E, Rose SS, Springer TA: Monocyte chemoattractant protein-1 acts as a T-lymphocyte chemoattractant. Proc Natl Acad Sci USA. 1994, 91: 3652-3656. 10.1073/pnas.91.9.3652.PubMed CentralView ArticlePubMedGoogle Scholar
- Dimitrijevic OB, Stamatovic SM, Keep RF, Andjelkovic AV: Effects of the chemokine CCL2 on blood-brain barrier permeability during ischemia-reperfusion injury. J Cereb Blood Flow Metab. 2006, 26: 797-810. 10.1038/sj.jcbfm.9600229.View ArticlePubMedGoogle Scholar
- Voorn Van der P, Tekstra J, Beelen RHJ, Tensen CP, Valk Van der P, De Groot CJA: Expression of MCP-1 by reactive astrocytes in demyelinating multiple sclerosis lesions. Am J Pathol. 1999, 154: 45-51.View ArticleGoogle Scholar
- Babcock AA, Kuziel WA, Rivest S, Owens T: Chemokine expression by glial cells directs leukocytes to sites of axonal injury in the CNS. J Neurosci. 2003, 23: 7922-7930.PubMedGoogle Scholar
- Grammas P, Ovase R: Inflammatory factors are elevated in brain microvessels in Alzheimer's disease. Neurobiol Aging. 2001, 22: 837-842. 10.1016/S0197-4580(01)00276-7.View ArticlePubMedGoogle Scholar
- Huang DR, Wang J, Kivisakk P, Rollins BJ, Ransohoff RM: Absence of monocyte chemoattractant protein 1 in mice leads to decreased local macrophage recruitment and antigen-specific T helper cell type 1 immune response in experimental autoimmune encephalomyelitis. J Exp Med. 2001, 193: 713-726. 10.1084/jem.193.6.713.PubMed CentralView ArticlePubMedGoogle Scholar
- Klingebiel R, Bendorf G, Schmitt M, von Moers A, Lehmann R: Large cerebral vessel occlusion disease in Lyme neuroborreliosis. Neuropediatrics. 2002, 33: 37-40. 10.1055/s-2002-23589.View ArticlePubMedGoogle Scholar
- Gadient RA, Otten UH: Interleukin-6 (IL-6) a molecule with both beneficial and destructive potential. Prog Neurobiol. 1977, 52: 379-390. 10.1016/S0301-0082(97)00021-X.View ArticleGoogle Scholar
- Raivich G, Jones LL, Werner A, Bluthmann H, Doetschmann T, Kreutzberg GW: Molecular signals for glial activation: Pro- and anti-inflammatory cytokines in the injured brain. Acta Neurochir. 1999, 21-30. Suppl 73Google Scholar
- Benveniste EN: Inflammatory cytokines within the central nervous system: sources, functions, and mechanisms of action. Am J Physiol. 1992, 263: C1-C5.PubMedGoogle Scholar
- Gareth RJ, Lee SC, Brosnan CF: Cytokines: Powerful regulators of glial cell activation. Neuroscientist. 2003, 9: 10-22. 10.1177/1073858402239587.View ArticleGoogle Scholar
- Habicht GS, Katona LI, Benach Jl: Cytokines and the pathogenesis of neuroborreliosis: Borrelia burgdorferi induces glioma cells to secrete interleukin-6. J Infect Dis. 1991, 164: 568-574.View ArticlePubMedGoogle Scholar
- Pachner AR, Amemiya K, Delaney E, O'Neil T, Hughes CAN, Zhang WF: Interleukin-6 is expressed at high levels in the CNS in Lyme neuroborreliosis. Neurology. 1997, 49: 147-152.View ArticlePubMedGoogle Scholar
- Ramesh G, Alvarez AL, Roberts ED, Dennis VA, Lasater BL, Alvarez X, Philipp MT: Pathogenesis of Lyme neuroborreliosis: Borrelia burgdorferi lipoproteins induce both proliferation and apoptosis in rhesus monkey astrocytes. Eur J Immunol. 2003, 33: 2539-2550. 10.1002/eji.200323872.View ArticlePubMedGoogle Scholar
- Kielian T: Microglia and chemokines in infectious diseases of the nervous system views and reviews. Front Biosci. 2004, 9: 732-750. 10.2741/1266.View ArticlePubMedGoogle Scholar
- Ransohoff RM, Glabinski A, Tani M: Chemokines in immune-mediated inflammation of the central nervous system. Cytokine and Growth Factor Rev. 1996, 7: 35-46. 10.1016/1359-6101(96)00003-2.View ArticleGoogle Scholar
- Cartier L, Hartley O, Dubois-Dauphin M, Krause KH: Chemokine receptors in the central nervous system: role in brain inflammation and neurodegenerative diseases. Brain Res Rev. 2005, 48: 16-42. 10.1016/j.brainresrev.2004.07.021.View ArticlePubMedGoogle Scholar
- Maderna P, Godson C: Phagocytosis of apoptotic cells and resolution of inflammation. Biochim Biophys Acta. 2003, 1639: 141-151.View ArticlePubMedGoogle Scholar
- Scheld WM, Koedel U, Nathan B, Pfister Hans W: Pathophysiology of bacterial meningitis: Mechanism(s) of neuronal injury. J Infec Dis. 2002, 186 (Suppl 225-S233).Google Scholar
- Nau R, Brück W: Neuronal injury in bacterial meningitis: mechanisms and implications for therapy. Trends Neurosci. 2002, 25: 38-45. 10.1016/S0166-2236(00)02024-5.View ArticlePubMedGoogle Scholar
- Kim YS, Sheldon RA, Elliot BR, Liu Q, Ferriero DM, Tauber MG: Brain injury in experimental neonatal injury due to group B streptococci. J Neuropathol Exp Neurol. 1995, 54: 531-539. 10.1097/00005072-199507000-00007.View ArticlePubMedGoogle Scholar
- Mitchell L, Smith SH, Braun JS, Herzog KH, Weber JR, Tuomanen EI: Dual phases of apoptosis in pneumococcal meningitis. J Infec Dis. 2004, 190: 2039-2046. 10.1086/425520.View ArticleGoogle Scholar
- Jessen KR: Glial cells. Int J Biochem Cell Biol. 2004, 36: 1861-1867. 10.1016/j.biocel.2004.02.023.View ArticlePubMedGoogle Scholar
- Hanani M: Satellite glial cells in sensory ganglia: from form to function. Brain Res Rev. 2005, 48: 457-476. 10.1016/j.brainresrev.2004.09.001.View ArticlePubMedGoogle Scholar
- England JD, Bohm R, Roberts ED, Philipp MT: Mononeuropathy multiplex in rhesus monkeys with chronic Lyme disease. Ann Neurol. 1997, 41: 375-84. 10.1002/ana.410410313.View ArticlePubMedGoogle Scholar
- Roberts ED, Bohm RP, Lowrie RC, Habicht G, Katona L, Piesman J, Philipp MT: Pathogenesis of Lyme neuroborreliosis in the rhesus monkey: The early disseminated and chronic phases of disease in the peripheral nervous system. J Infec Dis. 1998, 178: 722-732. 10.1086/515357.View ArticleGoogle Scholar
- Murphy PG, Grondin J, Altares M, Richardson PM: Induction of interleukin-6 in axotomized sensory neurons. J Neurosci. 1995, 15: 5130-5138.PubMedGoogle Scholar
- Murphy PG, Borthwick LA, Johnson RS, Kuchel G, Richardson PM: Nature of retrograde signal from injured nerves that induces interleukin-6 mRNA in neurons. J Neurosci. 1999, 19: 3791-3800.PubMedGoogle Scholar
- Ozaktay AC, Kallakuri S, Takebayashi T, Cavanaugh JM, Asik I, DeLeo JA, Weinstein JN: Effects of interleukin-1 beta, interleukin-6 and tumor necrosis factor on sensitivity of dorsal root ganglion and peripheral receptive fields in rats. Eur Spine J. 2006, 15: 1529-1537. 10.1007/s00586-005-0058-8.View ArticlePubMedGoogle Scholar
- Dominguez E, Rivat C, Pommier B, Mauborgne A, Pohl M: JAK/STAT3 pathway is activated in spinal cord microglia after peripheral nerve injury and contributes to neuropathic pain development in rat. J Neurochem. 2008, 107: 50-60. 10.1111/j.1471-4159.2008.05566.x.View ArticlePubMedGoogle Scholar
- Garcia-Moncó JC, Fernandez-Villar B, Benach JL: Adherence of the Lyme disease spirochete to glial cells and cells of glial origin. J Infect Dis. 1989, 160: 497-506.View ArticlePubMedGoogle Scholar
- Garcia-Moncó JC, Fernandez-Villar B, Rogers RC, Szczepanski A, Wheeler CM, Benach JL: Borrelia burgdorferi and other related spirochetes bind to galactocerebroside. Neurology. 1992, 4: 1341-1348.View ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.